Poster Presentations

Friday, October 12, 2018

Adjuvant endocrine therapy
P01 ANTI-HORMONAL THERAPY ALONE IN N1 STAGE BREAST CANCER PATIENTS WITH  HORMONE RECEPTOR POSITIVE AND HER-2 NEGATIVE
Sung-Ui Jung, South Korea
P02 MALE BREAST CANCER IN AUSTRALIA: COMPLIANCE WITH TREATMENT KEY PERFORMANCE INDICATORS – 99,768 BREAST CANCERS OVER A 10 YEAR PERIOD
Chris Lomma, Australia
P03 SYSTEMIC ADJUVANT TREATMENT RECOMMENDATIONS AND COMPLIANCE IN AUSTRALIAN PATIENTS WITH EARLY BREAST CANCER
Chris Lomma, Australia
Bone health
P04 PERCUTANEOUS PEDICLE SCREW FIXATION FOLLOWED BY CEMENTOPLASTY: A  MINIMALLY INVASIVE TECHNIQUE FOR SPINAL METASTASIS IN BREAST CANCER PATIENTS
Claudio Pusceddu, Italy
Breast cancer genetics
P05 PREVALENCE OF OESTROGEN RECEPTOR POSITIVE BREAST CANCER IN OBESITY PATIENTS: A RETROSPECTIVE STUDY
Nur Aziah Binti Adib Anuar, Malaysia
P06 LVI IS IT MORE WORSE PREDICT OUTCOME THAN WE BELIEVE WE KNOW ABOUT IT?
SYSTEMIC REVIEW OF SINGLE INSTITUTE IN SAUDI ARABIA
Abdulaziz Alhamad, Saudi Arabia
P07 METHYLATION STATUS OF MGMT AND MEG3 GENE’S PROMOTERS IN TRIPLE – NEGATIVE BREAST CANCER
Sylwia Sloniec, Poland
Breast imaging
P08 FEATURE OF THE BREAST LESION CAN BE DECEPTIVE: MIMICKERS OF BREAST MALIGNANCY
Visnja Baksa Reynolds, Singapore
P09 SHEAR WAVE ULTRASOUND AND HIGH MAMMOGRAPHIC BREAST DENSITY (HMBD);
A PILOT STUDY OF BREAST STIFFNESS REDUCTION IN PRE-MENOPAUSAL WOMEN WITH HMBD
Stephen Birrell, Australia
P10 LITERATURE REVIEW AND CASE REPORT OF GRANULAR CELL TUMOUR IN BREAST
Amy Cao, Australia
P11 THE IMPACT OF PRE-OPERATIVE MRI IN THE MANAGEMENT OF INVASIVE LOBULAR CARCINOMA OF THE BREAST
Jennifer Chang, New Zealand
P12 KEEP CALM, IT`S JUST `MOOBS`
Mei Chan Chin, Australia
P13 THE BRILLIANCE OF CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY (CESM)
Laurence Gluch, Australia
P14 COMPARISON OF USEFULNESS OF ULTRASOUND AND MRI FOR DIAGNOSIS OF SILICON BREAST IMPLANT RUPTURE
Naoya Gomi, Japan
P15 FEATURES OF IMAGE FINDINGS OF DIGITAL BREAST TOMOSYNTHESIS (DBT) UNDETECTED BREAST CANCER
Mari Kikuchi, Japan
P16 APPROACHING BREAST IMPLANT ASSOCIATED COMPLICATION WITH ULTRASOUND AND CHECKLIST
Angela Soeun Lee, South Korea
P17 SQUAMOUS CELL METAPLASIA OF LACTIFEROUS DUCTS IN MALE PATIENTS
Rachael Manning, Australia
P18 WHICH IS THE BETTER METHOD TO DETECT ABNORMALITIES BY VISUAL ESTIMATE OR VOLPARA FOR WOMEN WITH DENSE BREAST?
Misaki Matsuyanagi, Japan
P19 FALSE NEGATIVE ON COMPUTER-AIDED DETECTION APPLICATION IN PREOPERATIVE AUTOMATED BREAST ULTRASOUND OF BREAST CANCER PATIENTS
Jiwon Rim, South Korea
P20 IMPACT OF PRE-OPERATIVE BREAST MRI ON BREAST CANCER TREATMENT PLANNING
Masuma Sarker, UK
P21 THE BREAST CANCER RELATED-RISKS IN WOMEN WITH DENSE BREAST TISSUE IS CLARIFIED BY USING VOLPARATM
Terumasa Sawada, Japan
P22 DIAGNOSTIC VALIDITY OF SURGEON-PERFORMED BREAST ULTRASOUND FOR FEMALES WITH PALPABLE BREAST MASSES
Apple Valparaiso, Philippines
P23 THE DIFFERENTIAL DIAGNOSIS OF THE BREAST FINDINGS USING AUTOMATED BREAST VOLUME SCANNER (ABVS) AND ADVANCED ELASTOGRAPHY
Mihaela Vancu, Romania
P24 INFLUENCE OF PRE-OPERATIVE BREAST CANCER LOCALIZATION TECHNIQUES ON INFLUENCE OF PRE-OPERATIVE BREAST CANCER LOCALIZATION TECHNIQUES ON LYMPHOSCINTIGRAPHY
Shipra Verma, Australia
Breast reconstruction
P25 PREPECTORAL IMMEDIATE IMPLANT-BASED RECONSTRUCTION USING BRAXON:
AN ACELLULAR DERMAL MATRIX – NATIONAL AUDIT FROM THE UNITED KINGDOM
Dayalan Clarke, UK
Endocrine resistance
P26 RIBOCICLIB + FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE (HR+), HER2-NEGATIVE (HER2–) ADVANCED BREAST CANCER
(ABC): RESULTS FROM MONALEESA-3
Arlene Chan, UK
P27 SINGLE CENTER STUDY IN THE PHILIPPINES ON ERIBULIN MESYLATE IN METASTATIC BREAST CANCER FROM 2013-2016
Amabelle Trina Gerona, Philippines
Molecular assays
P28 OPTIMA: A PROSPECTIVE RANDOMISED TRIAL TO VALIDATE THE CLINICAL UTILITY AND COST-EFFECTIVENESS OF GENE EXPRESSION TEST-GUIDED CHEMOTHERAPY DECISIONS IN HIGH CLINICAL RISK EARLY BREAST CANCER
Janet Dunn, UK
P29 TUMOR MICROENVIRONMENT AND ITS PHARMACOLOGICAL MODULATION IN A BREAST CANCER MODEL: PARALLELS TO SKIN WOUND HEALING
Peter Gal, Slovakia
P30 EXPLORING IN VITRO ANDROGEN BIOASSAYS AS A CLINICAL TOOL FOR BREAST CANCER
Rachel Lund, New Zealand
Neoadjuvant therapy
P31 PATHOLOGIC OUTCOMES OF HER2 POSITIVE NON METASTATIC BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT DUAL ANTI HER2 THERAPY AND TAXANE AT SYDNEY ADVENTIST HOSPITAL (SAH)
Joseph Do Woong Choi, Australia
P32 DESIGN OF PERSIA: PERTUZUMAB STUDY FOR HER2-POSITIVE NON-METASTATIC BREAST CANCER IN THE NEOADJUVANT SETTING IN AUSTRALIA
Richard De Boer, Australia
P33 PREDICTIVE FACTORS OF STABLE OR PROGRESSIVE DISEASE DURING ANTHRACYCLINE WITH/WITHOUT TAXANE-BASED NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
Ji Young Kim, South Korea
Prevention
P34 EARLY-LIFE BODY FATNESS IN RELATION TO TEXTURE VARIATION ON A MAMMOGRAM
Hannah Oh, South Korea
P35 COMPLIANCE WITH MULTIDISCIPLINARY TEAM MEETING TREATMENT RECOMMENDATIONS
Amali Samarasinghe, Australia
Radiotherapy
P36 DOES THE TUMOR BED SURGICAL CLIPS AFFECT DOSIMETRIC CHANGES IN THREE  – DIMENSIONAL FIELD-IN-FIELD WHOLE-BREAST IRRADIATION TECHNIQUES FOR PATIENTS UNDERGOING BREAST CONSERVING SURGERY?
Dong Soo Lee, South Korea
Supportive care
P37 IMAGING-PROVEN VENOUS THROMBOEMBOLISM AMONG BREAST CANCER PATIENTS IN A TERTIARY HOSPITAL IN THE PHILIPPINES FROM 2010-2015
Amabelle Trina Gerona, Philippines
P38 THE EFFICACY OF BILASTINE FOR TAXANE REGIMENS INDUCED RASH
Taizo Hirata, Japan
P39 FEASIBILITY OF SEGMENTAL ECW/TBW RATIO FOR MILD TO MODERATE DEGREE  BREAST CANCER-RELATED LYMPHEMDEMA: CORRELATION WITH TAPE CIRCUMFERENTIAL VOLUME MEASUREMENT
Woo Gyeong Kim, South Korea
P40 CONSENT IN THE AGE OF WHITAKER AND MONTGOMERY: TIPTOEING THROUGH THE MINEFIELD OF PATIENT AUTONOMY
Mona Tan, Singapore
Survivorship
P41 LYMPHATIC MICROSURGICAL PREVENTING HEALING APPROACH (LYMPHA): A SYSTEMATIC REVIEW
Natalia Garibotto, Australia
P42 PLEOMORPHIC LOBULAR BREAST CANCER: DOES MORPHOLOGY MATTER?
Laurence Gluch, Australia
P43 ETHNIC DISPARITIES IN THE INCIDENCE OF PHYLLODES TUMOURS AT COUNTIES MANUKAU HEALTH
Megan Grinlinton, New Zealand
P44 UTILITY OF SERUM TUMOUR MARKER VELOCITY OF CANCER ANTIGEN 15-3 (CA15-3) AND CARCINOEMBRYONIC ANTIGEN (CEA) IN BREAST CANCER SURVEILLANCE
Jun Xian Hing, Singapore
P45 TREATMENT PATTERNS AND CLINICAL OUTCOMES IN ELDERLY BREAST CANCER PATIENTS
Eunyoung Kang, South Korea
P46 IMPACT OF VITAMIN D ON BREAST CANCER OUTCOME
Trisha Khoo, Australia
P47 OLIGOMETASTATIC BREAST CANCER: CAN WE EVER SAY CURE?
Tahlia Molinaro, Australia
P48 QUALITY OF LIFE AND BODY IMAGE IN WOMEN WITH SURGERY FOR BREAST CANCER IN SINGAPORE
Siau Wei Tang, Singapore
P49 ESTABLISHING ROUTINE COLLECTION OF PATIENT-REPORTED OUTCOMES VIA THE BREASTSURGANZ QUALITY AUDIT: A PROOF-OF-PRINCIPLE PROJECT TO TEST FEASIBILITY
David Walters, Australia
P50 BREAST CANCER FOLLOW-UP: THE PATIENTS PERSPECTIVE
Maggie Wilcox, UK
P51 PHYSIOTHERAPY MANAGEMENT OF BREAST CANCER TREATMENT-RELATED FATIGUE, LYMPHOEDEMA, METASTATIC AND RADIATION-INDUCED BRACHIAL PLEXOPATHY: A CASE REPORT
Wai Yeung, Australia
P52 WALKING THE BOUNDARIES: IS THE 6-MINUTE WALK TEST ACHIEVABLE IN A OUTPATIENT BREAST CLINIC?
Lei Ying, Australia
Triple negative breast cancer
P53 HEALTH CARE RESOURCE UTILIZATION FOR PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER (mTNBC) IN THE REAL WORLD CLINICAL SETTING: AN OBSERVATIONAL BREAST CANCER (OBTAIN) STUDY FROM AUSTRALIA
Elani Bowers, Australia
P54 THE MANAGEMENT OF BRCA PATIENTS IN THE WELLINGTON REGION: A 10 YEAR OVERVIEW
Sue Hui Ong, New Zealand
P55 RADIOGENOMIC ANALYSIS OF TRIPLE NEGATIVE BREAST CANCER: FEATURES OF RADIOMICS AND TRANSCRIPTOMICS
Sung Ui Shin, South Korea

Saturday, October 13, 2018

Breast cancer screening
P01 LOBULAR NEOPLASIA IN BREAST SCREEN SETTING MULTICENTRE STUDY (ST VINCENT AND MONASH) RETROSPECTIVE, DESCRIPTIVE STUDY: 23 YEARS (1993-2016)
Parisa Aminzadeh, Australia
P02 ZnR/GPR39 MODULATES KCC ACTIVITY IN ESTROGEN NEGATIVE BREAST CANCER CELLS
Moumita Chakraborty, Israel
P03 ROS-MEDIATED APOPTOSIS INDUCED BY FRUIT POLYPHENOLS IS FOLLOWED BY P38MAPK, ERK1/2 AND THE AKT SIGNALING PATHWAYS MODULATION IN BREAST CARCINOMA MODEL
Matus Coma, Slovakia
P04 IS ASYMPTOMATIC SURVEILLANCE AFTER STANDARD TREATMENT BENEFICIAL?: A 10 YR-SURVIVAL ANALYSIS OF RECURRENT BREAST CANCER PATIENTS BY DETECTION METHOD OF RECURRENCE
Han Shin Lee, South Korea
P05 OPTIMISING THE EARLY DETECTION OF BREAST CANCER IN AUSTRALIA
Carolyn Nickson, Australia
P06 USING THE GAIL MODEL TO RISK-STRATIFY WOMEN FOR BREAST CANCER SCREENING: MODEL VALIDATION ON 40,000 AUSTRALIAN WOMEN ATTENDING BREASTSCREEN
Carolyn Nickson, Australia
P07 SOME OPTIONS FOR COMBINING QUESTIONNAIRE AND MAMMOGRAPHIC DENSITY MEASURES TO ESTIMATE RISK OF FUTURE INVASIVE BREAST CANCER AND INTERVAL CANCERS IN SCREENED WOMEN
Carolyn Nickson, Australia
P08 MACHINE LEARNING MODELS FOR POPULATION-LEVEL RISK STRATIFICATION
Pietro Procopio, Australia
P09 RELIABILITY OF SUSPICION OF MALIGNANT BREAST MASS IN AUTOMATED BREAST ULTRASOUND (ABUS) EXAMINATION: AUTOMATED VERSUS HANDHELD BREAST ULTRASOUND
Jiwon Rim, South Korea
Breast reconstruction
P10 SCARLESS LATISSIMUS DORSI FLAP: AN EXCELLENT OPTION FOR LOWER POLE COVER IN IMPLANT BASED RECONSTRUCTION FOR A CHALLENGING SUBSET OF PATIENTS
Vanitha Budhavaram, Australia
P11 SINGLE PORT LAPAROSCOPIC HARVESTED OMENTAL FLAP FOR IMMEDIATE BREAST RECONSTRUCTION: EXPERIENCE IN SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL
Sumin Chae, South Korea
P12 DOES IMMEDIATE BREAST RECONSTRUCTION LEAD TO A DELAY IN ADJUVANT CHEMOTHERAPY FOR BREAST CANCER?: A META-ANALYSIS AND SYSTEMATIC REVIEW
Patrick Cook, Australia
P13 BREAST RECONSTRUCTION IN THE REGIONAL SETTING: 5 YEARS OF EXPERIENCE
Daniel Keating, Australia
P14 CLINICAL AUDIT REDUCTION MAMMOPLASTY FROM 2011 TO 2016: AN ASSESSMENT OF SURGICAL OUTCOME AND WAITING PERIOD IN A TERTIARY PUBLIC HOSPITAL
Jeffrey Smith, Australia
DCIS
P15 ACTIVE MONITORING VERSUS IMMEDIATE TREATMENT FOR WOMEN WITH LOCALISED, LOW-RISK DUCTAL CARCINOMA IN SITU: DOES IT MAKE ECONOMIC SENSE?
Hannah Bromley, Australia
P16 TRIPLE NEGATIVE DCIS
Sayuka Nakayama, Japan
Local therapy
P17 RADIO-GUIDED OCCULT LESION LOCALISATION USING IODINE-125 SEEDS (ROLLIS) IS A SAFE ALTERNATIVE TO HOOK-WIRE LOCALISATION (HWL)
Brenno Becker, Australia
P18 THE USE OF WIRELESS TECHNOLOGY IN BREAST CANCER: HOW TO START YOUR OWN RADIOGUIDED OCCULT LESION LOCALISATION PROGRAMME USING IODINE – 125 SEEDS (ROLLIS)
Brenno Becker, Australia
P19 CLINICOPATHOLOGIC PROFILE AND OUTCOMES OF PHYLLODES TUMOR OF THE BREAST: A 10-YEAR REVIEW OF A PHILIPPINE TERTIARY HOSPITAL EXPERIENCE
Shiela Macalindong, Philippines
P20 CAN METHYLENE BLUE DYE BE USED AS AN ALTERNATIVE TO PATENT BLUE DYE TO FIND THE SENTINEL LYMPH NODE IN BREAST CANCER SURGERY?
Omid Rouhbakhshfar, Iran
P21 MUCINOUS BREAST CARCINOMA. A SINGLE INSTITUTION EXPERIENCE
Nikolaos Salemis, Greece
P22 OPTIMAL TREATMENT MODALITY OF PSEUDOANGIOMATOUS STROMAL HYPERPLASIA OF THE BREAST
Kwanghyun Yoon, South Korea
Locoregional therapy
P23 LITERATURE REVIEW AND THREE CASE REPORTS OF BREAST FIBROMATOSIS:
A MASQUERADE OF BREAST CANCER
Amy Cao, 
Australia
P24 A NOVEL PREDICTIVE TOOL FOR HEAVY AXILLARY NODAL INVOLVEMENT IN SENTINEL NODE POSITIVE BREAST CANCER
Nipu Jayatilleke, 
Australia
P25 MAGNETIC TRACER USE FOR SENTINEL NODE BIOPSY: INTRODUCTION TO AN AUSTRALASIAN PILOT STUDY
Ahrin Anna Morrow, New Zealand
P26 IMPACT OF THE AMERICAN COLLEGE OF SURGEONS ONCOLOGY GROUP Z0011 TRIAL ON THE MANAGEMENT OF POSITIVE AXILLARY NODES IN THE AUSTRALIAN SETTING
Nicholas K. Ngui, 
Australia
P27 OUTCOMES OF RIB RESECTION FOR BREAST TUMORS EXTENDING TO THE CHEST WALL
Kristine Paguirigan, Philippines
P28 DISCUSSION ON INDICATIONS OF INTERNAL MAMMARY SENTINEL LYMPH NODE BIOPSY IN BREAST CANCER IN THE ERA OF PRECISION MEDICINE
Peng-Fei Qiu, China
P29 A PROSPECTIVE COMPARATIVE DOUBLE ARM  STUDY OF SLNB WITH ICG BASED TECHNIQUE VERSUS COMBINATION DUAL DYE TECHNIQUE FOR EARLY BREAST CANCER: FIRST INDIAN STUDY
S.P. Somashekhar, India
P30 THE ‘TWINKLE’ ARTEFACT: A NOVEL METHOD OF CLIP IDENTIFICATION TO FACILITATE TARGETED AXILLARY SURGERY FOLLOWING NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
Mona Tan, Singapore
P31 INDOCYANINE GREEN FLUORESCENCE VERSUS BLUE DYE OR RADIOISOTOPE FOR DETECTION RATE OF SENTINEL LYMPH NODE BIOPSY AND NODES REMOVED IN BREAST CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
Sarun Thongvitokomarn, Thailand
P32 BREAST CANCER ANATOMIC STAGING WITH RISK SCORE IS SIMPLE TO USE AND EFFECTIVE
Ru Xin Wong, Singapore
Oncoplastic surgery
P33 PERFORATOR FLAPS FOR BREAST CONSERVING SURGERY: RESULTS FROM AN EARLY SERIES
Nita Bartlett, Australia
P34 IMAGING RESULTS FOLLOWING PARTIAL BREAST RECONSTRUCTION WITH CHEST WALL PERFORATOR FLAPS: A QUALITATIVE ANALYSIS WHEN COMPARED TO STANDARD BREAST CONSERVING SURGERY
Jesse Hu, Singapore
P35 PREOPERATIVE 3D PRINTING TO AID PLANNING IN COMPLEX BREAST PROCEDURES
Railya Mousina, Australia
P36 DOES ONCOPLASTIC SURGERY HAVE A ROLE IN OPTIMISING BREAST CONSERVATION TREATMENT IN AN ASIAN CONTEXT?Mona Tan, Singapore
P37 EFFICACY AND SAFETY OF TRANEXAMIC ACID IN ONCOPLASTIC BREAST SURGERY: A SYSTEMATIC LITERATURE REVIEW
Kartik Vasan, Australia
P38 PRACTICE PATTERNS OF ANTIBIOTIC PROPHYLAXIS IN ONCOPLASTIC BREAST SURGERY: A NATIONWIDE AUSTRALIAN SURVEY
Kartik Vasan, Australia
Radiotherapy
P39 ACCELERATED PARTIAL BREAST IRRADIATION (APBI) WITH EXTRACRANIAL STEREOTACTIC RADIOTHERAPY (SBRT) AND EXACTRAC ADAPTIVE GATING IN LOW-RISK EARLY BREAST CANCER: 5-YEAR FOLLOW-UP
Angel Acosta Rojas, Spain
P40 POST-MASTECTOMY HYPOFRACTIONATED LOCOREGIONAL IRRADIATION (HLRI)
Angel Acosta Rojas, Spain
P41 HYPOFRACTIONATED RADIOTHERAPY IN LOCALLY ADVANCED BREAST CANCER AFTER CONSERVATIVE SURGERY
Angel Acosta Rojas, Spain
P42 HYPOFRACTIONATED ACCELERATED RADIOTHERAPY FOR DUCTAL CARCINOMA IN SITU (DCIS)
Angel Acosta Rojas, Spain
P43 INTRAOPERATIVE RADIOTHERAPY FOR EARLY STAGE BREAST CANCER AT THE MONASH CANCER CENTRE: FEASIBILITY AND ACUTE TOXICITY
Steven David, Australia
P44 DEVELOPMENT OF A TREATMENT TECHNIQUE FOR THE AEROFORM™ TISSUE EXPANDER BREAST IMPLANT SYSTEM: A SINGLE DEPARTMENT EXPERIENCE
Jennie Gilliman, Australia
P45 EVALUATION OF SETUP ACCURACY FOR PRONE BREAST RADIOTHERAPY WITH A 3D SURFACE IMAGING SYSTEM
Sunmi Jo, South Korea
P46 DEEP INSPIRATION BREATH HOLD COMPLIANCE RATE AT SIMULATION AT GENESISCARE VICTORIA
Cynleen Kai, Australia
P47 COMPARING EVIDENCE-BASED RECOMMENDATIONS FOR RADIOTHERAPY USE AGAINST ROUTINE PRACTICE IN BREAST CANCER
Roya Merie, Australia
P48 UTILITY OF DEEP INSPIRATORY BREATH HOLD (DIBH) IN THE RADIOTHERAPEUTIC MANAGEMENT OF RIGHT SIDED BREAST CANCER
Andrew See, Australia
P49 PARADIGMS IN BREAST CANCER MANAGEMENT IN PREVIOUSLY AUGMENTED BREASTS: TIME FOR A CHANGE?
Kartik Vasan, Australia
Molecular assays
P50 NETRIN-1 EXPRESSION IN BREAST CANCER
Shyr-Ming Sheen-Chen, Taiwan